Home / Inspections / 1025777

FDA Inspection 1025777 — Center for Reproductive Medicine

Center for Reproductive Medicine — FEI 3005950704

The FDA completed an inspection of Center for Reproductive Medicine on September 1, 2017 in Minneapolis, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 1, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Minneapolis, MN (United States)

Facility

Other inspections at this facility

  • 1260495 (NAI Thu Feb 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1107360 (NAI Wed Oct 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 889603 (NAI Thu Jul 31 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 795285 (NAI Mon Aug 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 654606 (VAI Tue Mar 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources